GlassScriptPhysician profile
Shawn S Rai
NPI 1073900064
$2,511.08
in general payments reported to CMS, 2019-2025
8 companies · $1,552 in 2025
The $1,552 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.79 · 2022: $163 · 2023: $258 · 2024: $522 · 2025: $1,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,324 · Travel and Lodging: $7.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,324.08 |
| Travel and Lodging | $7.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,871.49 | 2022-2025 | Mazor X System, Catalyft Pl Expandable Interbody System, Stealthstation S8 Platform |
| Orthofix Medical, INC. | $305.42 | 2025 | Explorer To, Northstar |
| Surgical Theater. INC. | $183.38 | 2023-2025 | |
| Arteriocyte Medical Systems, INC. | $37.90 | 2025 | Magellan |
| Monteris Medical Corporation | $34.71 | 2025 | Neuroblate |
| Si-Bone, INC. | $34.20 | 2023 | |
| Bioventus LLC | $27.19 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Glaxosmithkline, LLC. | $16.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Rai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.